Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $86.37 USD
Change Today +0.26 / 0.30%
Volume 1.1M
As of 8:04 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

omnicare inc (OCR) Snapshot

Open
$86.16
Previous Close
$86.11
Day High
$87.29
Day Low
$86.01
52 Week High
04/22/15 - $90.49
52 Week Low
04/28/14 - $57.83
Market Cap
8.4B
Average Volume 10 Days
1.8M
EPS TTM
$2.82
Shares Outstanding
96.9M
EX-Date
03/10/15
P/E TM
30.6x
Dividend
$0.88
Dividend Yield
0.97%
Current Stock Chart for OMNICARE INC (OCR)

omnicare inc (OCR) Related Businessweek News

View More BusinessWeek News

omnicare inc (OCR) Details

Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States. The company’s Long-Term Care Group segment offers pharmaceuticals, and related pharmacy and ancillary services to long-term care facilities; and chronic care facilities and other settings. This segment also operates institutional pharmacy business serving skilled nursing and assisted living facilities, independent living communities, hospitals, correctional facilities, and other healthcare service providers; and provides monthly patient drug therapy evaluations, and assistance in compliance with state and federal regulations, as well as offers proprietary clinical and health management programs. In addition, it provides a suite of technology solutions based on its Omniview Web-based platform as the electronic ordering of prescription refills, proof-of-delivery tracking, and real-time validation of Medicare Part D coverage; intravenous medications and nutrition products, respiratory therapy services, and clinical care planning services; and pharmaceutical case management services for retirees, employees, and dependents. Its Specialty Care Group segment provides specialty pharmacy and commercialization services for the biopharmaceutical industry; and provides brand support services, supply chain solutions, patient support services, and specialty pharmacy platforms. This segments specialized drugs deal primarily with drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology, and growth hormones. Omnicare, Inc. was founded in 1981 and is headquartered in Cincinnati, Ohio.

11,726 Employees
Last Reported Date: 02/25/15
Founded in 1981

omnicare inc (OCR) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $753.8K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $492.7K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $470.9K
Chief Human Resources Officer and Senior Vice...
Total Annual Compensation: $346.7K
Senior Vice President of Commercial Operation...
Total Annual Compensation: $342.0K
Compensation as of Fiscal Year 2014.

omnicare inc (OCR) Key Developments

Omnicare Reportedly Explores Sale

Omnicare Inc. (NYSE:OCR) is exploring a sale, according to sources close to the matter, according to Bloomberg. Omnicare is working with financial advisers as it seeks buyers, the people reportedly said. The sale process is at an early stage and its possible no deal will be reached, the people said, according to the report.

Kentucky Joins Lawsuit against Omnicare Inc., Claiming Billions in Losses

Kentucky has joined in on a federal lawsuit against Omnicare Inc., claiming the company falsely billed the state for nearly $6 billion. According to a story from the Kentucky Center for Investigative Reporting, papers filed by Attorney General Jack Conway in federal court allege that Omnicare billed the state's Medicaid program for more than $6 billion over nine years to cover drugs that were given to nursing home patients for uses that weren't approved by the Food and Drug Administration. The filing says Omnicare received millions in kickbacks from Abbott Laboratories for promoting the use of its anti-seizure and mood disorder drug for agitated or aggressive dementia patients that led to some of the billings.

Long Term Care Group Reports Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Long term care group reported unaudited earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales of $1,185.0 million compared to $1,169.1 million a year ago. Adjusted operating income was $151.3 million compared to $160.4 million a year ago. For the year, the company reported net sales of $4,750.1 million compared to $4,627.9 million a year ago. Adjusted operating income was $632.2 million compared to $634.1 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCR:US $86.37 USD +0.26

OCR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brookdale Senior Living Inc $36.68 USD -0.65
Cintas Corp $81.62 USD -0.51
MEDNAX Inc $72.83 USD -0.58
Patterson Cos Inc $47.37 USD -0.82
Waters Corp $122.00 USD -1.54
View Industry Companies
 

Industry Analysis

OCR

Industry Average

Valuation OCR Industry Range
Price/Earnings 49.7x
Price/Sales 1.3x
Price/Book 3.3x
Price/Cash Flow 57.7x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OMNICARE INC, please visit www.omnicare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.